[Ip-health] AFP: Brazil, India urge WHO to dump drug firms from counterfeit fight
ssangeeta at myjaring.net
Wed May 19 15:28:05 PDT 2010
Published on France24 (http://www.france24.com/en)
Home > Brazil, India urge WHO to dump drug firms from counterfeit fight
Brazil, India urge WHO to dump drug firms from counterfeit fight
Created 19/05/2010 - 19:52
Brazil and India on Wednesday urged the World Health Organisation to cut its
link with big pharmaceutical firms in the fight against counterfeit
They claim that these major drugmakers are unfairly labelling generic
medicines as counterfeits, and using the fight against fake medication to
suppress competitors who are making lawful generic drugs.
"A divorce is inevitable," Brazil said at the annual World Health Assembly
meeting in Geneva this week.
Brazil and India are big producers of generic drugs.
Together with some Latin American and African developing countries, the two
countries called on the WHO to end a partnership established in 2006 called
IMPACT (International Medical Products Anti-Counterfeiting Taskforce), which
includes groups that represent the interest of pharmaceutical firms.
The group also includes key inter-governmental agencies such as Interpol,
the World Customs Organization, the World Bank and the World Trade
"The role of IMPACT is controversial," said India, adding that governments
should be the ones in charge of the fight against counterfeit medicines.
In response, WHO director-general Margaret Chan only said that IMPACT was
created before she arrived at the WHO.
To that, Kenya offered a riposte, telling Chan: "If you're not satisfied
with the marriage, you could ask for a divorce."
The proliferation of potentially lethal or harmful counterfeit medicines has
been on the rise, particularly with the increased usage of the Internet
According to the WHO, more than half of all medicines bought online are
Malaria treatments are the main counterfeit medicines sold by criminal
organisations, according to the International Pharmaceutical Federation,
which represents two million pharmacists worldwide.
More information about the Ip-health